Peripheral Inflammation Markers of Chemosensitivity to Induction Chemotherapy in Hypopharyngeal Cancer Patients

ORL J Otorhinolaryngol Relat Spec. 2019;81(2-3):82-91. doi: 10.1159/000499474. Epub 2019 May 21.

Abstract

Background: Induction chemotherapy (ICT) has become an initial treatment for late-stage hypopharyngeal squamous cell carcinoma (SCC); however, there are no data regarding ICT sensitivity for this population.

Objective: This study investigated the predictive value of various inflammation markers for ICT responses in hypopharyngeal SCC.

Methods: The data from 72 patients who received initial ICT treatment were obtained and associations between pretreatment inflammation markers and overall responses to ICT were calculated.

Results: According to receiver operating characteristic curves, pretreatment lymphocyte count (PLC), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) achieved diagnostic accuracy for overall responses to ICT. These indicators were classified into two groups according to their cut-off values. Overall response rates were significantly higher in the low PLC (p < 0.01), high NLR (p = 0.035), and high PLR (p = 0.012) groups.

Conclusion: Our results showed that low PLC, high NLR, and high PLR are predictors of positive responses to ICT in hypopharyngeal SCC patients.

Keywords: Chemosensitivity; Hypopharyngeal squamous cell carcinoma; Neutrophil-to-lymphocyte ratio; Platelet-to-lymphocyte ratio; Pretreatment lymphocyte count.

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Blood Platelets / pathology*
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Hypopharyngeal Neoplasms / pathology
  • Hypopharyngeal Neoplasms / therapy*
  • Induction Chemotherapy
  • Inflammation / pathology*
  • Leukocyte Count
  • Lymphocytes / pathology*
  • Male
  • Middle Aged
  • Neutrophils / pathology*
  • Prognosis
  • ROC Curve
  • Retrospective Studies

Substances

  • Antineoplastic Agents